Alpha Cognition, Inc. embarked on research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS), also called Lou Gehrig’s Disease. To date, both conditions have serious unmet medical needs. Current therapies for these two diseases only treat symptoms or, in the case of ALS, have a modest effect in slowing its progression.